Use of low density lipoprotein particle number levels as an aid in statin treatment decisions for intermediate risk patients: a cost-effectiveness analysis

BACKGROUND: The 2013 ACC/AHA guideline recommended either no statin therapy or moderate-intensity statin therapy (MST) for intermediate risk patients—those with 5–7.5% 10-year risk and without cardiovascular disease (CVD), hypercholesterolemia or diabetes. The guideline further suggested that the th...

Descripción completa

Detalles Bibliográficos
Autores principales: Shiffman, Dov, Arellano, Andre R., Caulfield, Michael P., Louie, Judy Z., Bare, Lance A., Devlin, James J., Melander, Olle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5142314/
https://www.ncbi.nlm.nih.gov/pubmed/27927162
http://dx.doi.org/10.1186/s12872-016-0429-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5142314/
https://www.ncbi.nlm.nih.gov/pubmed/27927162
http://dx.doi.org/10.1186/s12872-016-0429-6

Ejemplares similares